This Startup Wants to Make IVF Easier and Less Invasive

February 9, 2026

Lab-based ovarian support cells, shorter stimulation, and in vitro egg maturation—innovation that puts the patient experience first

Gameto and IVF: Easier, Less Invasive Fertility Care on the Horizon

A biotech company called Gameto is developing lab based ovarian support cells that could let immature eggs mature in vitro, potentially reducing the need for daily hormone injections and addressing ovarian aging—a huge area of interest for future fertility care. If you are exploring IVF or egg freezing, you may have heard about shorter stimulation, fewer injections, or an “ovary in a dish” approach. These ideas can feel hopeful, but also uncertain when you are already weighing complex medical options and emotions.

This article explains what Gameto’s technology aims to do, how it could change the patient experience, and why Her Serenity cares about sharing clear, honest information about emerging science so you can slow down, ask better questions, and make choices that feel right—without pressure.

This Startup Wants to Make IVF Easier and Less Invasive

Understanding Gameto’s Approach to IVF

What is Gameto developing, and how could it affect treatment?

Gameto is developing Fertilo, a biotechnology treatment that uses lab engineered ovarian support cells derived from human induced pluripotent stem cells to improve IVF and egg freezing. These young, engineered cells are designed to mature eggs in a dish by replicating the natural maturation process outside the body. The goal is to reduce the physical and emotional burden of traditional stimulation while still supporting healthy egg development and embryo formation.

In practice, this approach could shorten the IVF timeline from roughly two weeks of daily hormone injections to about three days with minimal hormonal stimulation. That shift could make fertility treatment faster, safer, and more accessible for people who are put off by two weeks of injections or side effects.

In Vitro Egg Maturation and Ovarian Support Cells

How do lab based ovarian support cells work?

Traditionally, IVF relies on strong hormonal stimulation to prompt the ovaries to produce multiple mature eggs at once. Patients give themselves daily injections for approximately two weeks, attend monitoring appointments, and may experience side effects. The process is effective for many people, but it can be demanding on the body, schedule, and emotions.

Gameto’s approach aims to support egg maturation in the lab instead. By co culturing immature eggs with lab derived ovarian support cells, the company hopes to achieve maturation that would otherwise require longer, higher dose stimulation. Research published in Human Reproduction has shown that this type of support can improve oocyte maturation and healthy embryo formation compared to some existing in vitro maturation options.

In theory, this could mean:

  • Shorter stimulation and fewer daily injections for patients
  • Options that make treatment feasible for people who cannot or prefer not to do two weeks of hormones
  • Potential applications for ovarian aging and future fertility care

It is important to remember that this technology is still in development and clinical research. Not every clinic offers it yet, and outcomes will continue to be studied as more data becomes available.

Benefits of Reducing the Burden of IVF

What are the potential advantages of easier, less invasive options?

When fertility care becomes less burdensome, more people may be able to consider it. Gameto’s work, and similar innovation, could offer several meaningful benefits:

  • Less physical burden. Fewer injections and shorter stimulation may mean fewer side effects, less disruption to daily life, and a treatment experience that feels more manageable.
  • Greater accessibility. Options that reduce the friction of treatment—how it is delivered, not only how it is navigated—could make IVF or egg freezing feasible for people who were previously hesitant.
  • Innovation that puts the patient first. Research focused on ovarian aging and in vitro maturation aligns with a broader shift toward care that prioritizes both outcomes and experience.
  • Clearer conversation about the future. When emerging science is explained honestly, patients can think ahead with clarity and ask better questions.

These benefits are about possibility and direction. As with any new technology, evidence will continue to grow, and your care team can help you understand what is available today versus what may become available tomorrow.

What to Keep in Mind About Emerging Fertility Technology

How can I stay informed without feeling pressured?

When you hear about “ovary in a dish,” shorter protocols, or ovarian aging research, it helps to keep a few things in mind:

  • Timeline and availability. Not every innovation is available at every clinic yet. Some approaches are still in clinical trials or early adoption.
  • Evidence and transparency. Ask what peer reviewed research supports a treatment, what outcomes were measured, and how it fits with your diagnosis and goals.
  • No pressure. Learning about what might become possible is not the same as being told you must try it. Informed, low pressure decision making is the goal.
  • Your values matter. Some people want to wait for more data; others are comfortable exploring newer options with a clear eyed view of what is known and unknown.
  • Emotional clarity. Hope and caution can coexist. You deserve information that helps you make choices that feel right for you, without hype or pressure.

Being aware of both the promise and the limits of emerging science can help you ask better questions and decide what path aligns with your values and your body.

Questions to Ask About New IVF and Egg Freezing Options

How can I talk with my care team about innovations like Gameto’s?

If you are curious about shorter stimulation, in vitro egg maturation, or ovarian aging research, you have every right to ask for clear explanations. Helpful questions include:

  • Is this approach available at my clinic or in my region, and if so, for which patients?
  • What does the research show so far, and what outcomes are being studied?
  • How would this change my timeline, injections, and monitoring compared to a standard protocol?
  • What are the potential benefits and limitations for someone in my situation?
  • How do you explain emerging options so I can make an informed choice without feeling rushed?

Your team should be comfortable discussing both what is available now and what may be on the horizon, and should welcome your questions rather than rushing past them.

Deciding What Path Is Right for You

How do I know whether to explore newer options or stick with current protocols?

There is no single answer that works for everyone. For some patients, the possibility of shorter stimulation and fewer injections is compelling. For others, a well established protocol with a long track record feels more appropriate. Both are valid.

It can be helpful to reflect on questions such as:

  • Do I understand what this option does and what the evidence shows so far?
  • Does exploring emerging science align with my values and comfort level?
  • Do I feel my care team is transparent about what is known and not yet known?

The right path is the one that combines sound information with your personal preferences and emotional needs.

How Her Serenity Approaches Innovation in Fertility Care

What is Her Serenity’s philosophy on easier, less invasive treatment?

At Her Serenity, we believe that removing the friction in fertility includes not only navigation and information, but also how treatment itself is delivered. That means:

  • Staying informed about emerging science—like Gameto’s work—so we can explain it clearly and honestly.
  • Prioritizing the patient experience: innovation that puts you first, and options that could make treatment feasible for more people.
  • Sharing transparent, educational information so you can slow down, ask better questions, and make choices that feel right, without pressure.

We see technologies that reduce burden and improve accessibility as aligned with our values. Your goals, your story, and your comfort level always come first—whether you choose established protocols or are curious about what might become possible.

Taking the Next Step

How can I learn more and decide what is right for me?

If you are curious about Gameto’s approach, shorter stimulation, or ovarian aging research— or you simply want to understand what options exist today—you are not alone. These are important topics, and you deserve time, clarity, and support as you make decisions.

You can schedule a consultation to review your history, discuss what is available now and what may be on the horizon, and ask every question on your mind. Together, we can decide what path aligns with your needs and values, with no pressure—just clear, honest information.

Your path to parenthood is personal. Emerging science should inform that path, not overwhelm it. With the right information and a compassionate team beside you, you can think ahead with clarity and move forward feeling informed and empowered.

Blog Category
Take Care When It Matters – Visible, Transparent, Accessible
When you recognize it is time to seek care. We are visible, transparent, and accessible.
Contact Us
Share this article